Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

125.03
Delayed Data
As of Jul 22
 -0.12 / -0.10%
Today’s Change
81.79
Today|||52-Week Range
126.07
+21.72%
Year-to-Date
3 Healthcare Stocks to Hold Forever
12:07pm / MotleyFool.com - Paid Partner Content
Abbott (ABT) Beats on Earnings & Sales in Q2, Maintains View
Jul 20 / Zacks.com - Paid Partner Content
2 Cheap High-Yield Dividend Stocks for Your Retirement Portfolio
Jul 22 / MotleyFool.com - Paid Partner Content
10 Best Dividend Stocks to Own Now for a Safe Retirement
Jul 20 / TheStreet.com - Paid Partner Content
L'Oréal Will Apply IT Cosmetics for $1.2B
Jul 22 / TheStreet.com - Paid Partner Content
Valeant's Drug Approvals May Save the Day
Jul 20 / TheStreet.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Dollar Shaving Club: smooth cut
Jul 20 / FT.com - Paid Partner Content
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter
Jul 22 / GuruFocus News - Paid Partner Content
5 Low Beta Stocks to Protect Your Gains
Jul 20 / Zacks.com - Paid Partner Content
Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson
Jul 22 / MotleyFool.com - Paid Partner Content
Zacks Market Edge Highlights: Lockheed Martin, Johnson & Johnson, IBM, AMN Healthcare...
Jul 20 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: J&J, IBM, AmEx Earnings Impress, Microsoft Misses on Revenues
Jul 22 / Zacks.com - Paid Partner Content
Stock Market News for July 20, 2016
Jul 20 / Zacks.com - Paid Partner Content
Stryker (SYK) Tops Q2 Earnings, Stock Down on Dull Q3 View
Jul 22 / Zacks.com - Paid Partner Content
3 Compelling Reasons to Buy Johnson & Johnson Following Earnings
Jul 20 / TheStreet.com - Paid Partner Content
Medical Stocks Reporting Early Next Week: GILD, LLY & More
Jul 22 / Zacks.com - Paid Partner Content
Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles
Jul 20 / TheStreet.com - Paid Partner Content
Zacks Earnings Trends Highlights: J.P. Morgan, Microsoft, Johnson & Johnson and Gener...
Jul 22 / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: Take Bristol-Myers Over Juno
Jul 20 / TheStreet.com - Paid Partner Content
Don't Disrespect This Bull Market
Jul 22 / TheStreet.com - Paid Partner Content
Cramer: In Earnings Tests, JNJ Gets an A While Netflix Flunks
Jul 19 / TheStreet.com - Paid Partner Content
11 Big Brands Stats That Will Blow You Away
Jul 22 / MotleyFool.com - Paid Partner Content
Jim Cramer's 'Mad Money' Recap: Why Some Stocks Pass Earnings Test and Others Fail
Jul 19 / TheStreet.com - Paid Partner Content
Is the Earnings Picture Improving?
Jul 21 / Zacks.com - Paid Partner Content
Should You Buy Stocks at the All Time Highs?
Jul 19 / Zacks.com - Paid Partner Content
Is the Earnings Picture Improving?
Jul 21 / Zacks.com - Paid Partner Content
Microsoft in Focus as Stock Valuation Gains Ease Slightly
Jul 19 / GuruFocus News - Paid Partner Content
T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter
Jul 21 / GuruFocus News - Paid Partner Content
Yacktman Focused Fund, Focuses Elsewhere
Jul 19 / GuruFocus News - Paid Partner Content
What Will Happen to the Stock Market When Interest Rates Rise? Part 1
Jul 21 / GuruFocus News - Paid Partner Content
Can Procter & Gamble Find Its Lost Mojo?
Jul 19 / GuruFocus News - Paid Partner Content
Johnson & Johnson (JNJ) Gets Price Target Hike at Deutsche Bank
Jul 21 / TheStreet.com - Paid Partner Content
Johnson & Johnson Boosts Dow, Netflix Pressures the S&P 500
Jul 19 / TheStreet.com - Paid Partner Content
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
Jul 21 / Zacks.com - Paid Partner Content
Johnson & Johnson (JNJ) Stock Rises, CFO Talks M&A
Jul 19 / TheStreet.com - Paid Partner Content
Research Reports on Facebook (FB), Tesla (TSLA) & Others
Jul 21 / Zacks.com - Paid Partner Content
Johnson & Johnson Hits Record High Despite Declines in Baby Care
Jul 19 / TheStreet.com - Paid Partner Content
The Best Long-Term Stocks to Buy
Jul 21 / MotleyFool.com - Paid Partner Content
Stocks Fluctuate as Johnson & Johnson Climbs, Netflix Shares Tumble
Jul 19 / TheStreet.com - Paid Partner Content
Show me the money! Dividends are all the rage
Jul 21 / CNNMoney.com
Why Berkshire Hathaway Dumped Johnson & Johnson
Jul 19 / GuruFocus News - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: International Business Machines, Intel, Johnson & ...
Jul 19 / Zacks.com - Paid Partner Content
4 Healthcare Mutual Funds to Buy on Bright Prospects
Jul 21 / Zacks.com - Paid Partner Content
Jim Cramer — J&J Is an Absolutely Terrific Stock
Jul 19 / TheStreet.com - Paid Partner Content
Here's My Top Stock to Buy in July
Jul 20 / MotleyFool.com - Paid Partner Content
Johnson & Johnson Keeps Growing on Pharma Strength
Jul 19 / MotleyFool.com - Paid Partner Content
Sizing Up the Q2 Earnings Season
Jul 20 / Zacks.com - Paid Partner Content
J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook
Jul 19 / Zacks.com - Paid Partner Content